HomeRGC • NASDAQ
add
Regencell Bioscience Holdings Ltd
Previous close
$13.13
Day range
$12.61 - $13.51
Year range
$0.093 - $83.60
Market cap
6.64B USD
Avg Volume
193.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 896.08K | -26.09% |
Net income | -865.30K | 22.58% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -876.65K | 22.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.90M | -38.49% |
Total assets | 5.76M | -31.79% |
Total liabilities | 895.31K | 307.86% |
Total equity | 4.86M | — |
Shares outstanding | 494.49M | — |
Price to book | 1.31K | — |
Return on assets | -38.92% | — |
Return on capital | -41.45% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -865.30K | 22.58% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Website
Employees
12
